Canakinumab in patients with Schnitzler's syndrome
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Canakinumab (Primary)
- Indications Schnitzler syndrome
- Focus Therapeutic Use
- 17 Dec 2013 New trial record
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.